Literature DB >> 21389594

Fatal 2009 pandemic influenza A (H1N1) in a bone marrow transplant recipient.

Anselmo Abdo1, Carlos Alfonso, Guillermo Diaz, Mario Wilford, Maykel Rocha, Niurka Verdecia.   

Abstract

Conditions characterized by immunosuppression have been recently reported as risk factors for severe novel swine-origin influenza A (H1N1) virus (S-OIV) infection during the current 2009 pandemic.  We report clinical and virological findings, antiviral therapy, and post-mortem study of S-OIV in an adult bone marrow transplant recipient. The viral genome was amplified by real time reverse transcriptase polymerase chain reaction (RT-PCR) from a nasopharyngeal swab specimen. The patient developed acute respiratory distress syndrome, septic shock, and eventually succumbed with a severe pulmonary haemorrhage. To the best of our knowledge, the entire clinical/therapy management and pathological examination in a transplant recipient infected with the S-OIV has not been previously documented. The fatal ending in this bone marrow transplant recipient supports recommendations that call for education measures, S-OIV vaccination, early diagnosis and aggressive treatment in the transplant population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389594     DOI: 10.3855/jidc.1066

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  1 in total

1.  Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice.

Authors:  Amber Farooqui; Alberto J Leon; Yanchang Lei; Pusheng Wang; Jianyun Huang; Raquel Tenorio; Wei Dong; Salvatore Rubino; Jie Lin; Guishuang Li; Zhen Zhao; David J Kelvin
Journal:  Virol J       Date:  2012-06-06       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.